WCM
AMRX icon

Wedge Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Wedge Capital Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-31,203
Closed -$62K – 428
2022
Q4 		$62K Hold
31,203
– – ﹤0.01% 418
2022
Q3 		$63K Hold
31,203
– – ﹤0.01% 403
2022
Q2 		$99K Buy
31,203
+1,176
+4% +$4.26K ﹤0.01% 404
2022
Q1 		$125K Buy
30,027
+214
+0.7% +$948 ﹤0.01% 415
2021
Q4 		$143K Buy
29,813
+6,763
+29% +$33.7K ﹤0.01% 406
2021
Q3 		$123K Buy
23,050
+4,448
+24% +$22.4K ﹤0.01% 399
2021
Q2 		$95K Buy
+18,602
New +$106K ﹤0.01% 392

Other funds holding AMRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
EP
Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return